[
  {
    "ts": null,
    "headline": "How Recent Developments Are Shaping the Boston Scientific Investment Story",
    "summary": "Boston Scientific's stock has seen a modest increase in its consensus analyst price target, rising slightly from $126.14 to $126.48. This minor upward adjustment reflects a balance between recent optimism around the company's earnings momentum, strategic acquisitions, and longer-term growth strategy. At the same time, there are more cautious views regarding current valuation and potential market risks. To discover how investors and analysts can keep up with the evolving story of Boston...",
    "url": "https://finnhub.io/api/news?id=87c07dbc48b1fbe0ae10766b7696a0bc8d942fe115288bdfd7f0caf214f9ad19",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762579214,
      "headline": "How Recent Developments Are Shaping the Boston Scientific Investment Story",
      "id": 137378428,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific's stock has seen a modest increase in its consensus analyst price target, rising slightly from $126.14 to $126.48. This minor upward adjustment reflects a balance between recent optimism around the company's earnings momentum, strategic acquisitions, and longer-term growth strategy. At the same time, there are more cautious views regarding current valuation and potential market risks. To discover how investors and analysts can keep up with the evolving story of Boston...",
      "url": "https://finnhub.io/api/news?id=87c07dbc48b1fbe0ae10766b7696a0bc8d942fe115288bdfd7f0caf214f9ad19"
    }
  }
]